載入...

Safety of a Four‐factor Prothrombin Complex Concentrate Versus Plasma for Vitamin K Antagonist Reversal: An Integrated Analysis of Two Phase IIIb Clinical Trials

OBJECTIVES: Clinicians often need to rapidly reverse vitamin K antagonists (VKAs) in the setting of major hemorrhage or urgent need for surgery. Little is known about the safety profile of the traditional reversal agent, plasma, or the newly approved agent, four‐factor prothrombin complex concentrat...

全面介紹

Na minha lista:
書目詳細資料
發表在:Acad Emerg Med
Main Authors: Milling, Truman J., Refaai, Majed A., Sarode, Ravi, Lewis, Brandon, Mangione, Antoinette, Durn, Billie L., Harman, Amy, Lee, Martin L., Goldstein, Joshua N.
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2016
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5071715/
https://ncbi.nlm.nih.gov/pubmed/26822172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acem.12911
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!